当前位置:首页 - 行情中心 - 大唐药业(920433) - 财务分析 - 资产负债表

大唐药业

(920433)

  

流通市值:7.94亿  总市值:12.00亿
流通股本:1.69亿   总股本:2.56亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金12,489,732.1829,712,104.1219,479,569.8419,793,224.25
  交易性金融资产20,425,791.655,388,469.725,369,717.727,427,670.4
  应收票据及应收账款23,072,031.4129,616,763.9433,536,869.351,358,623.19
  其中:应收票据2,538,208.555,720,731.746,631,364.261,011,540.91
        应收账款20,533,822.8623,896,032.226,905,505.0450,347,082.28
  应收款项融资7,402,122.1833,207,953.1125,296,419.06-
  预付款项6,549,111.815,002,105.834,488,411.2910,199,796.84
  其他应收款合计478,344.82781,428.64252,339.95409,257.21
  存货48,056,053.8452,262,227.3450,571,914.2253,289,990.88
  一年内到期的非流动资产-147,012.65293,458.49-
  其他流动资产47,021.89-860,709.52762,966.64
  流动资产合计118,520,209.78156,118,065.35140,149,409.37163,241,529.41
非流动资产:
  固定资产350,151,860.26349,978,558.38363,653,158.43375,819,969.35
  在建工程3,347,757.554,657,497.654,114,484.911,842,424.46
  使用权资产1,638,789.731,685,177.11,731,564.471,777,951.84
  无形资产20,620,145.8520,789,701.520,959,257.1520,383,928.31
  长期待摊费用2,821,248.513,376,661.733,018,515.063,516,420.41
  递延所得税资产10,303,459.248,609,260.159,145,610.4411,985,308.58
  其他非流动资产1,779,517.422,479,585.21,141,875.092,742,509.14
  非流动资产合计390,662,778.56391,576,441.71403,764,465.55418,068,512.09
  资产总计509,182,988.34547,694,507.06543,913,874.92581,310,041.5
流动负债:
  短期借款71,648,202.5488,849,718.7275,384,627.5183,718,313.28
  应付票据及应付账款16,131,816.7826,410,883.4732,714,867.526,858,221.54
        应付账款16,131,816.7826,410,883.4732,714,867.526,858,221.54
  合同负债15,479,828.8814,966,703.2519,217,874.4516,426,545.3
  应付职工薪酬4,208,210.686,567,403.275,358,351.12,604,534.36
  应交税费463,201.542,792,021.171,593,511.46113,876.45
  其他应付款合计4,518,806.015,029,289.914,341,434.55,597,274.32
  一年内到期的非流动负债-283,982.15283,982.15523,671.02
  其他流动负债6,566,177.494,072,688.185,608,175.252,676,028.59
  流动负债合计119,016,243.92148,972,690.12144,502,823.92138,518,464.86
非流动负债:
  租赁负债423,072.85278,939.93414,571.79307,127.62
  长期应付款407,249.94407,249.94407,249.94407,249.94
  递延收益17,220,702.4618,061,266.3518,467,416.7619,811,310.42
  递延所得税负债254,053.08297,929.1261,826.21294,991.35
  非流动负债合计18,305,078.3319,045,385.3219,551,064.720,820,679.33
  负债合计137,321,322.25168,018,075.44164,053,888.62159,339,144.19
所有者权益(或股东权益):
  实收资本(或股本)255,919,681255,919,681255,919,681255,919,681
  资本公积128,961,697.08128,961,697.08128,961,697.08128,961,697.08
  盈余公积33,361,972.9433,361,972.9433,361,972.9433,361,972.94
  未分配利润-46,381,684.93-38,566,919.4-38,383,364.723,727,546.29
  归属于母公司股东权益合计371,861,666.09379,676,431.62379,859,986.3421,970,897.31
  股东权益合计371,861,666.09379,676,431.62379,859,986.3421,970,897.31
  负债和股东权益合计509,182,988.34547,694,507.06543,913,874.92581,310,041.5
公告日期2026-08-272026-04-292026-04-292025-10-29
审计意见(境内)标准无保留意见
TOP↑